Debiopharm
Switzerland - LausanneCDMO (Contract Manufacturing)
Focus: Debiopharm is a Swiss-based Contract Development & Manufacturing Organization (CDMO) specializing in oncology, infectious diseases, and other therapeutic areas with a lean team of 1-50 employees. The company operates as a private entity focused on drug development and manufacturing services.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Employees
1-50
Open Jobs
14+2 this month
Stable — net +2 jobs in 30d
5 added, 3 removed. Backfill posture.
Should You Work at Debiopharm?
AI assessmentDebiopharm suits early-career biotech professionals seeking hands-on CDMO/development experience in a startup environment, but lacks the resources, pipeline maturity, and transparency typical of stable mid-cap employers.
Why Work Here
- Access to diverse pipeline of 20+ clinical trials spanning oncology, infectious diseases, and cardiovascular indications — meaningful exposure to early-stage drug development
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Alisporivir
Hepatitis CClinical Trials (1)
NCT01970904Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients
N/AHelp build intelligence for Debiopharm
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.